COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem
Ann Hepatol
.
2021 Sep-Oct:24:100525.
doi: 10.1016/j.aohep.2021.100525.
Authors
Pathum Sookaromdee
1
,
Viroj Wiwanitkit
2
Affiliations
1
Private Academic Consultant, Bangkok Thailand. Electronic address: pathumsook@gmail.com.
2
Honorary professor, Dr DY Patil University, Pune, India.
PMID:
34509271
PMCID:
PMC8425075
DOI:
10.1016/j.aohep.2021.100525
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Jaundice* / diagnosis
Jaundice* / etiology
Liver
SARS-CoV-2
Thrombocytopenia* / diagnosis
Substances
COVID-19 Vaccines